ArticleJournal of cancer research and clinical oncology2023

Pretreatment lymphocyte-monocyte ratio (LMR) as a superior predictor of short-term progression outcomes in patients with gastric cancer receiving second- and later-line apatinib regimens.

Hao Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.